openPR Logo
Press release

Investigation announced for Investors in shares of LivaNova PLC (NASDAQ: LIVN) ver possible Violations of Securities Laws

08-08-2024 08:14 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in LivaNova PLC (NASDAQ: LIVN) shares over potential securities laws violations by LivaNova PLC

An investigation for investors in LivaNova PLC (NASDAQ: LIVN) shares over potential securities laws violations by LivaNova PLC

An investigation was announced for investors of LivaNova PLC (NASDAQ: LIVN) shares over potential securities laws violations by LivaNova PLC.

Investors who purchased shares of LivaNova PLC (NASDAQ: LIVN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of LivaNova PLC (NASDAQ: LIVN) concerning whether a series of statements by LivaNova PLC regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

United Kingdom based LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide.

LivaNova PLC reported that its annual Total Revenue rose from over $1.02 billion in 2022 to over $1.15 billion in 2023, and that its Net Loss of $86.24 million in 2022 turned toa Net Income of $17.54 million in 2023.

On June 6, 2024, LivaNova issued a press release "announc[ing] the preliminary results for the unipolar patient cohort of the RECOVER clinical study, assessing the use of VNS Therapy™ in treatment-resistant depression", advising that "[t]he study did not meet its primary endpoint (PE) for the unipolar cohort[.]"

Shares of LivaNova PLC (NASDAQ: LIVN) $64.47 per share on May 06, 2024 to as low as $47.75 per share on August 01, 2024.

Those who purchased shares of LivaNova PLC (NASDAQ: LIVN) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of LivaNova PLC (NASDAQ: LIVN) ver possible Violations of Securities Laws here

News-ID: 3616343 • Views:

More Releases from Shareholders Foundation

Investigation announced for Long-Term Investors in shares of Ocugen, Inc. (NASDAQ: OCGN)
Investigation announced for Long-Term Investors in shares of Ocugen, Inc. (NASDA …
An investigation was announced over potential breaches of fiduciary duties by certain directors and officers of Ocugen, Inc. Investors who are current long term investors in Ocugen, Inc. (NASDAQ: OCGN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: OCGN stocks follows a lawsuit filed against Ocugen, Inc. over alleged
Investigation announced for Investors who lost money with shares of Dayforce Inc (NYSE: DAY)
Investigation announced for Investors who lost money with shares of Dayforce Inc …
An investigation was announced for investors of Dayforce Inc (NYSE: DAY) shares over potential securities laws violations by Dayforce Inc. Investors who purchased shares of Dayforce Inc (NYSE: DAY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Dayforce Inc regarding its business, its prospects and its operations were materially
Investigation announced for Investors who lost money with shares of Dril-Quip, Inc. (NYSE: DRQ)
Investigation announced for Investors who lost money with shares of Dril-Quip, I …
An investigation was announced for investors of Dril-Quip, Inc. (NYSE: DRQ) shares over potential securities laws violations by Dril-Quip, Inc. Investors who purchased shares of Dril-Quip, Inc. (NYSE: DRQ), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Dril-Quip, Inc. (NYSE: DRQ) concerning whether a series
Investigation announced for Investors in shares of Xiao-I Corporation (NASDAQ: AIXI) over potential Wrongdoing
Investigation announced for Investors in shares of Xiao-I Corporation (NASDAQ: A …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Xiao-I Corporation. Investors who purchased shares of Xiao-I Corporation (NASDAQ: AIXI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Xiao-I Corporation directors breached their fiduciary duties and caused damage to the company and its shareholders. China based Xiao-I Corporation,

All 5 Releases


More Releases for LivaNova

CPB Machines market: Technological Advancements in 2022 | LivaNova, Getinge, Med …
" The global CPB Machines Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global CPB Machines Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global
Cardiac Monitoring & Cardiac Rhythm Market is Estimated to Grow at a Significant …
This Cardiac Monitoring & Cardiac Rhythm market analysis report aims to provide a solid platform to reduce business risks and deal with major changes take place in the business. Successful company strategies provided here help major players to expand business and make an effective business growing plan. It helps key organizations to deal with continuously changing business scenario. It eases different company activities around the company. This Cardiac Monitoring &
Bioelectric Medicine Market Seeking New Epic Growth | Biotronik, Livanova, Cochl …
Global Bioelectric Medicine Market breaking major business segments and highlighting wider level geographies to get deep dive analysis on market data. The study is a perfect balance bridging both qualitative and quantitative information of Bioelectric Medicine market. The study provides valuable market size data for historical (Volume** & Value) from 2016 to 2020 which is estimated and forecasted till 2026*. Some are the key & emerging players that are part
Bioelectric Medicine Market Worth Observing Growth | Livanova, Biotronik, Nevro
A new business intelligence report released by HTF MI with title "Global Bioelectric Medicine Market Size, Status and Forecast 2019-2025" is designed covering micro level of analysis by manufacturers and key business segments. The Global Bioelectric Medicine Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and
Perfusion Market Analysis and Trends to 2025 | Getinge, Medtronic, LivaNova
The Global Perfusion market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Perfusion Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Perfusion market.
LivaNova PLC (LIVN) Product Pipeline Analysis, & Forecast Report 2018
A fresh report has been added to the wide database of Market Research Hub (MRH) titled “LivaNova PLC (LIVN) Product Pipeline Analysis, & Forecast Report 2018”which provides an outlook of current market value as well as the expected forecast of Rate on Investment (ROI) with growing CAGR of XX% during stated forecast from 2018-2025. This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of